CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia

被引：49
|
作者：
Meisel, Roland [1 ]
机构：
[1] Heinrich Heine Univ, Dusseldorf, Germany
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2021年 / 384卷 / 23期
关键词：
BCL11A;
D O I：
10.1056/NEJMc2103481
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia
    Norton, Mary E.
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2021, 76 (06) : 327 - 329
  • [2] CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia
    Haydar Frangoul
    四川生理科学杂志, 2020, 42 (04) : 506 - 506
  • [3] CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia
    Frangoul, H.
    Altshuler, D.
    Cappellini, M. D.
    Chen, Y-S
    Domm, J.
    Eustace, B. K.
    Foell, J.
    de la Fuente, J.
    Grupp, S.
    Handgretinger, R.
    Ho, T. W.
    Kattamis, A.
    Kernytsky, A.
    Lekstrom-Himes, J.
    Li, A. M.
    Locatelli, F.
    Mapara, M. Y.
    de Montalembert, M.
    Rondelli, D.
    Sharma, A.
    Sheth, S.
    Soni, S.
    Steinberg, M. H.
    Wall, D.
    Yen, A.
    Corbacioglu, S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (03): : 252 - 260
  • [4] CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia
    Lakshmi, Dhanya N.
    INDIAN PEDIATRICS, 2022, 59 (06) : 458 - 458
  • [5] CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia REPLY
    Frangoul, Haydar
    Ho, Tony W.
    Corbacioglu, Selim
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (23):
  • [6] Approval of the First CRISPR-Cas9 Gene Editing Therapy for Sickle Cell Disease
    Campbell, Sean T.
    CLINICAL CHEMISTRY, 2024, 70 (10) : 1298 - 1298
  • [7] Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia
    Parums, Dinah, V
    MEDICAL SCIENCE MONITOR, 2024, 30
  • [8] CRISPR/Cas9 gene editing for curing sickle cell disease
    Park, So Hyun
    Bao, Gang
    TRANSFUSION AND APHERESIS SCIENCE, 2021, 60 (01)
  • [9] Genome editing using CRISPR-Cas9 to create the HPFH genotype in HSPCs: An approach for treating sickle cell disease and β-thalassemia
    Ye, Lin
    Wang, Jiaming
    Tan, Yuting
    Beyer, Ashley I.
    Xie, Fei
    Muench, Marcus O.
    Kan, Yuet Wai
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (38) : 10661 - 10665
  • [10] Controlling CRISPR-Cas9 Gene Editing
    Dowdy, Steven F.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (03): : 289 - 290
12345